Open AccessHealthcare Resource Utilization and Costs in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration
Author(s) -
Ashley Kim,
Beth Devine,
Joanna Campbell,
Elaheh Shirneshan,
Changgeng Zhao,
Aasthaa Bansal
Publication year - 2021
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s307603
Subject(s) - medicine , geographic atrophy , macular degeneration , disease , disease burden , retrospective cohort study , lesion , health care , pediatrics , emergency medicine , ophthalmology , surgery , economics , economic growth
Geographic atrophy (GA) is an advanced form of nonexudative age-related macular degeneration (AMD) that lacks treatment options. With considerable interpatient variability in the rate of GA progression due to lesion characteristics, information characterizing the disease burden is limited. The aim of this study was to describe the healthcare resource utilization (HCRU) and costs associated with increasing severity levels of GA.